Inhibition of beta-lactamase-mediated oxacillin resistance in Staphylococcus aureus by a deoxyribozyme (Q46933455)

26 December 2017

title

Inhibition of beta-lactamase-mediated oxacillin resistance in Staphylococcus aureus by a deoxyribozyme (English)

1 reference

26 December 2017

main subject

Staphylococcus aureus

1 reference

Zheng Hou

1

1 reference

26 December 2017

Jing-ru Meng

2

1 reference

26 December 2017

Jin-rong Zhao

3

1 reference

26 December 2017

Ben-quan Hu

4

1 reference

26 December 2017

Jie Liu

5

1 reference

26 December 2017

Xiao-jun Yan

6

1 reference

26 December 2017

Min Jia

7

1 reference

26 December 2017

Xiao-xing Luo

8

1 reference

26 December 2017

publication date

1 November 2007

1 reference

26 December 2017

Acta Pharmacologica Sinica

published in

1 reference

26 December 2017

volume

28

1 reference

26 December 2017

issue

11

1 reference

26 December 2017

page(s)

1775-1782

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1111/j.1745-7254.2007.00646.x

exact match

0 references

cites work

Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

The emergence of severe, community-acquired methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Vancomycin resistance in staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Signaling antibiotic resistance in staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Antimicrobial resistance: the example of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Deoxyribozymes: new activities and new applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Comparison of two standardisation methods in real-time quantitative RT-PCR to follow Staphylococcus aureus genes expression during in vitro growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Quantification of bacterial transcripts during infection using competitive reverse transcription-PCR (RT-PCR) and LightCycler RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Surveillance and epidemiology of MRSA bacteraemia in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Inhibition of Aminoglycoside 6′- N -Acetyltransferase Type Ib-Mediated Amikacin Resistance by Antisense Oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Bactericidal antisense effects of peptide-PNA conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Antimycobacterial activities of antisense oligodeoxynucleotide phosphorothioates in drug-resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Restoration of oxacillin susceptibility in methicillin-resistant Staphylococcus aureus by blocking the MecR1-mediated signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00646.X

10.1111/J.1745-7254.2007.00646.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

Dimensions Publication ID

1047630200

0 references

1 reference

26 December 2017